Browse CATs

Browse CATs  internal medicine  pulmonary medicine  exacerbation of chronic obstructive pulmonary disease

Diagnosis Prognosis Therapy Antibiotics Other drugs Oxygen Respiratory failure Smoking cessation Steroids

COPD exacerbation: methylxanthines improve symptoms but causes nausea and vomiting Level of evidence 1a- Expiry Date COPD exacerbation: mucolytics have no clear effect Level of evidence 2a- Expiry Date COPD ipratropium bromide decreases therapy time. Level of evidence 1b Expiry Date Acute airways disease fenoterol and ipratropium improve FEV1 . Level of evidence 1b- Expiry Date June 2002 Airflow obstruction ipratropium bromide added to salbutamol improved peak flow more effectively than salbutamol alone. Level of evidence 1b Expiry Date May 2002 COPD magnesium sulphate added to albuterol had no clear effect. Level of evidence 1b- Expiry Date November 2001 COPD exacerbation: no clear benefit from ipratropium Level of evidence 1b- Expiry Date November 2001 COPD exacerbations: no clear role of aminophylline Level of evidence 1b- Expiry Date November 2001 COPD immunostimulating agents had no clear effect. Level of evidence 1b- Expiry Date November 2001 COPD mucolytics reduce exacerbations and days of disability. Level of evidence 1a Expiry Date November 2001 Chronic obstructive pulmonary disease immunostimulating agents had no clear effect. Level of evidence 1b- Expiry Date November 2000